• Profile
Close

Aggressive surgery for stage III/IV epithelial ovarian cancer

Gynecologic Oncology Aug 16, 2017

Tate S et al. – In the current study it was shown that outcomes improved after implementing aggressive surgery for advanced ovarian cancer.

Methods

  • 106 patients with stage III/IV ovarian, fallopian, and peritoneal cancer undergoing elective aggressive surgery were studied.

Results

  • The median progression-free and overall survival rates increased from 14.6 and 38.1?months before implementation of aggressive surgery, respectively, to 25.0 and 68.5?months after implementation, respectively.
  • Complete resection was achieved in 83 of 106 patients, and the surgical complexity score was high (>8) in 61 patients.
  • There were no mortality within 12?weeks of surgery.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay